-transparent.png){kind=logo}
Pinane thromboxane A2 (PTA2) an analog of thromboxane A2 that inhibits the formation of thromboxanes as well as antagonizes their biological actions, at an infusion rate of 1.0 mumole . kg-1 . h-1, prolonged survival in traumatic shock in rats. PTA2 also prevented the accumulation of thromboxane B2, the lysosomal protease, cathepsin D, and the cardiotoxic peptide MDF in the circulating blood.
Related Publications
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
January 1988,
Prostaglandins,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
June 1990,
European journal of pharmacology,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
January 1989,
Eicosanoids,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
February 1990,
Journal of cardiovascular pharmacology,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
June 1980,
Circulation research,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
June 1983,
Prostaglandins, leukotrienes, and medicine,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
July 1988,
Methods and findings in experimental and clinical pharmacology,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
January 1994,
Pharmacological research,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
January 1984,
Circulatory shock,
A M Lefer, and
H Araki, and
J B Smith, and
K C Nicolaou, and
R L Magolda
June 1997,
Prostaglandins, leukotrienes, and essential fatty acids,
